RefinedScience systematically de-risks drug programs in oncology and immunology drug assets by integrating high-fidelity clinical data with single-cell human tissue biology and functional testing to drive actionable insight from target to trial.
Who We Are
We combine clinical datasets, primary tissue analysis, and computational methods to generate insight that moves programs forward with greater confidence.
To enable better drug development decisions by connecting human biology, clinical data, and computational insight into a unified, decision-ready framework.
A future where every drug development decision is informed by real human biology, reducing failure, accelerating timelines, and bringing more effective therapies to patients.
Our Team
Let’s build the evidence that moves your program forward.